Individualized Surgical Management for Thyroglossal Duct Cyst‐Papillary Thyroid Carcinoma: A Case Series
The Laryngoscope · 2025-10 · 135 (10) · 3951-3956
DOI: 10.1002/lary.32403 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Laryngoscope, online erschienen am 12.07.2025. Verfasst von Rockey Dahiya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Mayo Clinic, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Precision Medicine, Thyroglossal Cyst, Thyroid Cancer, Papillary, Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
Thyroglossal duct cyst (TGDC) associated carcinoma is rare, accounting for less than 2% of TGDC cases. The majority of cases are classified as papillary thyroid carcinoma (PTC). Standard treatment for TGDC‐PTC involves a Sistrunk procedure and prophylactic total thyroidectomy (TT). However, the necessity of these extensive surgical interventions remains debated. This report aims to explore whether individualized surgical approaches may reduce morbidity while maintaining favorable oncological outcomes.
Methods
Retrospective case series of three patients with TGDC‐PTC.
Results
The age range at presentation for our patients with TGDC‐PTC was 26 to 50. Case 1 involved a 38‐year‐old patient with a cystic mass near the hyoid bone and submental lymphadenopathy who underwent cyst excision with level Ia lymph node clearance. Case 2 is of a 50‐year‐old patient with a history of TGDC‐PTC who presented with a recurrent neck mass 9 years after the initial surgery and underwent a revision Sistrunk procedure. Case 3 presents a 26‐year‐old patient with a large TGDC and a benign thyroid nodule who underwent a Sistrunk procedure. All three patients had PTC confirmed by final pathology. All had no evidence of recurrent disease at follow‐up evaluations ranging from 1 to 12 years.
Conclusion
This case series demonstrates the feasibility and safety of individualized surgical management for TGDC‐PTC. Risk stratification allowed for tailored interventions and avoided overly aggressive approaches. Further studies are needed to establish definitive guidelines for managing TGDC‐PTC, particularly in low‐risk patients. Level of Evidence 4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology - Head and Neck Surgery, Mayo Clinic, Jacksonville, Florida, USA.
- Division of Endocrinology, Mayo Clinic, Jacksonville, Florida, USA.
- Department of Pathology and Laboratory Medicine, Mayo Clinic, Jacksonville, Florida, USA.
ORCID-Profile: Natalie Weiss
Zitieren
APA
Dahiya, R., Weiss, N., May, R., Chindris, A. M., Reynolds, J. P., Janus, J. R., & Pirgousis, P. (2025). Individualized Surgical Management for Thyroglossal Duct Cyst‐Papillary Thyroid Carcinoma: A Case Series. The Laryngoscope, 135(10), 3951-3956. https://doi.org/10.1002/lary.32403
Vancouver
Dahiya R, Weiss N, May R, Chindris AM, Reynolds JP, Janus JR, et al. Individualized Surgical Management for Thyroglossal Duct Cyst‐Papillary Thyroid Carcinoma: A Case Series. The Laryngoscope. 2025;135(10):3951-3956. doi:10.1002/lary.32403
BibTeX
@article{Dahiya2025,
author = {Dahiya, Rockey and Weiss, Natalie and May, Ryan and Chindris, Ana-Maria and Reynolds, Jordan P and Janus, Jeffrey R and Pirgousis, Phillip},
title = {Individualized Surgical Management for Thyroglossal Duct Cyst‐Papillary Thyroid Carcinoma: A Case Series},
journal = {The Laryngoscope},
year = {2025},
volume = {135},
number = {10},
pages = {3951--3956},
doi = {10.1002/lary.32403}
}
EUVIMED